SPP1+ TAMs may promote FAP+ CAFs proliferation through ADM-(CALCRL/RAMP1), and FAP+ CAFs may modulate endothelial and tumor cell function and growth by VEGFB (Figure S10E & S10F)67. The gene discussed is CALCRL; the disease is neoplasm.